Novel 16S rRNA Methyltransferase RmtH Produced by
A minoglycosides, along with ␤-lactams and fluoroquinolones, remain one of the key classes of antimicrobial agents in the treatment of infections caused by Gram-negative bacteria. Mechanisms of resistance to aminoglycosides include enzymatic modification of the drugs, modification of the aminoglycoside-binding site, decreased permeability across the bacterial outer membranes, and augmented efflux. Among them, production of acquired 16S rRNA methyltransferase (16S RMTase) is the most worrisome since it compromises the activity of all aminoglycosides (1). Since the initial reports in 2003, nine such enzymes have been identified (1, 2, 18) . With the exception of NpmA, which methylates residue A1408 of the 16S rRNA, they methylate residue G1405 and confer high-level resistance to all aminoglycosides formulated for intravenous use, including gentamicin, tobramycin, amikacin, and arbekacin. Among the G1405 16S RMTases, ArmA and RmtB appear to be the most widely distributed worldwide, having been found in multiple species of the Enterobacteriaceae, as well as Pseudomonas aeruginosa and Acinetobacter baumannii. Production of 16S RMTases is frequently accompanied by coproduction of a carbapenemase or extended-spectrum ␤-lactamase (ESBL), which further facilitates multidrug resistance. In the United States, the most commonly encountered 16S RMTase is ArmA, produced by multidrug-resistant (MDR) and extensively drug-resistant (XDR) A. baumannii, whereas the presence of RmtB and RmtE has been reported for rare strains of Escherichia coli.
In this article, we describe identification of RmtH, a novel 16S RMTase, in a clinical strain of Klebsiella pneumoniae. K. pneumoniae MRSN2404 was recovered from a 28-year-old male soldier who had suffered a tibial fracture from an explosion in Iraq in 2006. The strain was collected by the Multidrug-resistant Organism Repository and Surveillance Network (MRSN) to enhance infection prevention, inform empirical therapy, and influence policy (3) . Following evacuation to the United States, a culture from the intramedullary wound of the right tibia grew XDR A. baumannii, ESBL-producing K. pneumoniae, and vancomycin-resistant enterococci. Subsequently, the patient had chronic draining wounds associated with the blast injury that occasionally expressed shrapnel. K. pneumoniae MRSN2404 was then isolated from the wound in 2009. This strain was found to have very high FIG 1 Phylogenetic tree of G1405 16S RMTases. The tree was generated using the tools available at http://www.phylogeny.fr (17) . GenBank references are as follows: ArmA, AY220558; RmtA, AB120321; RmtB1, AB103506; RmtB2, JN968578; RmtC, AB194779; RmtD1, DQ914960; RmtD2, HQ401565; RmtE, GU201947; RmtF, JQ808129; RmtG, JX486113. 
MICs (Ͼ256 g/ml) of all aminoglycosides tested, including gentamicin, tobramycin, amikacin, and arbekacin, when tested by the standard broth microdilution method recommended by the Clinical and Laboratory Standards Institute (4). It was also resistant to ceftriaxone, ceftazidime, cefepime, aztreonam, and ciprofloxacin but remained susceptible to ertapenem and imipenem. The strain was phenotypically confirmed as an ESBL producer, and screening of ␤-lactamase genes with PCR and sequencing showed that it carried bla CTX-M-15 as well as bla SHV-1 and bla OXA-1 . Multilocus sequence typing (www.pasteur.fr/mlst) (5) assigned the strain to sequence type (ST) 48, an ST which has been reported in association with ESBL production worldwide (6-10).
Given the resistance phenotype consistent with 16S RMTase production, the strain was screened for 16S RMTase genes using PCR (2, 11, 12) . However, PCR was negative for all known 16S RMTase genes. We therefore proceeded with further experiments to identify the determinant of high-level aminoglycoside resistance. The genomic DNA of K. pneumoniae MRSN2404 was extracted, digested with KpnI (New England BioLabs, Ipswich, MA), and ligated with the vector pBC-SK(Ϫ) (Agilent Technologies, Santa Clara, CA), which had been digested with the same enzyme. Electrocompetent Escherichia coli DH10B was transformed with this genomic library, and transformants were selected on tryptic soy agar (TSA) plates containing chloramphenicol (30 g/ml) and gentamicin (50 g/ml). This procedure yielded a single colony, which was cross-resistant to other aminoglycosides as well. The recombinant plasmid harbored by this transformant (pKp2404K1) was then fully sequenced. The sequencing revealed the presence of a 3.1-kb insert, which contained an open reading frame (ORF) corresponding to a 252-amino-acid sequence. This ORF showed 64% amino acid identity with the 16S RMTases RmtB1 and RmtB2 and 63% identity with RmtA. Identity with other 16S RMTases was much lower, ranging from 25% with ArmA to 39% with RmtD1, RmtD2, and RmtF (Fig. 1) . The ORF was designated rmtH according to the proposed nomenclature of acquired 16S RMTases (13) . We then performed PCR cloning of rmtH using the primers rmtH-XbaI-fwd (5=-CGCTCTAGAATG ACCATTGAACAGGCAGC-3=) and rmtG-BamHI-rev (5=-CGC GGATCCTCAAGCTGGGTTTGGCTGGA-3=) (the restriction sites are underlined). The PCR product was digested with XbaI and BamHI and ligated with pBC-SK(Ϫ) digested with the same enzymes. Transformants were obtained using the method above. A transformant harboring a recombinant plasmid with the intact rmtH structural gene (prmtHBX7), as confirmed by sequencing, was used for susceptibility testing. Susceptibility testing was performed using Etest (bioMérieux, Hazelwood, MO) according to the manufacturer's instructions. As shown in Table 1 , the original genomic clone, as well as the PCR clone, showed high-level resistance to gentamicin, tobramycin, and amikacin, as expected. Based on the pattern of aminoglycoside resistance and the amino acid alignment with known 16S RMTases, RmtH likely functioned as a G1405 16S RMTase (Fig. 2) .
The full sequence of pKp2404K1 revealed that rmtH was bracketed by two copies of ISCR2 in tandem. ISCR2 is an IS91-like transposable element which is found in association with various resistance genes, including those for sulfonamide, trimethoprim, and florfenicol (14) , and also tetracycline and cephalosporin (15, 16) . It is believed to facilitate mobilization of the genetic elements downstream. To our knowledge, this is the first instance where a 16S RMTase gene was found in association with ISCR2. ISCR2 is usually found intact upstream of a resistance gene, while the second copy downstream is typically truncated (14) . Since ISCR2 possesses a KpnI restriction site, we were not able to assess whether the two copies of ISCR2 were intact or not. Nonetheless, this unique arrangement suggested that they likely played a role in the initial mobilization of rmtH to K. pneumoniae MRSN2404.
Attempts to mobilize rmtH to E. coli by either transformation or conjugation were not successful. DNA hybridization of S1 nuclease-treated genomic DNA separated by pulsed-field gel electrophoresis (PFGE) with an rmtH-specific probe did not yield any band despite the presence of multiple plasmids on the PFGE gel. Finally, the rmtH probe hybridized to an approximately 500-kb band which was generated by PFGE following XbaI digestion (data not shown). These findings suggested that rmtH was likely located on the chromosome.
In summary, we report a novel 16S RMTase, RmtH, identified in an ESBL-producing K. pneumoniae strain which was recovered from a soldier who had been wounded during an operation in Iraq. The finding underscores the diversity of 16S RMTases and highlights the importance of continued surveillance in identifying emerging antimicrobial resistance mechanisms.
Nucleotide sequence accession number. The nucleotide sequence reported in this study has been submitted to the GenBank under accession number KC544262.
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